Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Novel Therapies for Glioblastoma
Elisa K. Liu, Erik P. Sulman, Patrick Y. Wen, et al.
Current Neurology and Neuroscience Reports (2020) Vol. 20, Iss. 7
Closed Access | Times Cited: 63

Showing 1-25 of 63 citing articles:

A Review of Newly Diagnosed Glioblastoma
Bryan Oronsky, Tony R. Reid, Arnold L. Oronsky, et al.
Frontiers in Oncology (2021) Vol. 10
Open Access | Times Cited: 129
Advances in immunotherapy for glioblastoma multiforme
Ahmad Bakur Mahmoud, Reham Ajina, Sarah Aref, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 66
The influence of the blood–brain barrier in the treatment of brain tumours
Sneha Rathi, Jessica I. Griffith, Wenjuan Zhang, et al.
Journal of Internal Medicine (2022) Vol. 292, Iss. 1, pp. 3-30
Closed Access | Times Cited: 41
Novel Treatment Strategies for Glioblastoma
Stanley S. Stylli
Cancers (2020) Vol. 12, Iss. 10, pp. 2883-2883
Open Access | Times Cited: 63
Immunostimulant In Situ Hydrogel Improves Synergetic Radioimmunotherapy of Malignant Glioblastoma Relapse Post‐Resection
Shuo Sun, Wei Gu, Haisi Wu, et al.
Advanced Functional Materials (2022) Vol. 32, Iss. 43
Open Access | Times Cited: 33
Nanomedicine for glioblastoma: Progress and future prospects
Imran Khan, Mohammad Hassan Baig, Sadaf Mahfooz, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 172-186
Closed Access | Times Cited: 28
Programmed cell death disrupts inflammatory tumor microenvironment (TME) and promotes glioblastoma evolution
Tingyu Liang, Lingui Gu, Xiaoman Kang, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 6
Leveraging extrachromosomal DNA to fine-tune trials of targeted therapy for glioblastoma: opportunities and challenges
Imran Noorani, Paul S. Mischel, Charles Swanton
Nature Reviews Clinical Oncology (2022) Vol. 19, Iss. 11, pp. 733-743
Closed Access | Times Cited: 23
Lipid-hybrid cell-derived biomimetic functional materials: A state-of-the-art multifunctional weapon against tumors
Wen-Shang Liu, Lili Wu, Cui-Min Chen, et al.
Materials Today Bio (2023) Vol. 22, pp. 100751-100751
Open Access | Times Cited: 13
Immune Cell Interplay in the Fight Against GBM
Nico Vallieri, Angeliki Datsi
Cancers (2025) Vol. 17, Iss. 5, pp. 817-817
Open Access
Multi-responsive nanofibers composite gel for local drug delivery to inhibit recurrence of glioma after operation
Yufu Zhu, Jun Jia, Gang Zhao, et al.
Journal of Nanobiotechnology (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 30
Laser hyperthermia: Past, present, and future
Alexander J. Schüpper, Tori Chanenchuk, Anna Racanelli, et al.
Neuro-Oncology (2022) Vol. 24, Iss. Supplement_6, pp. S42-S51
Open Access | Times Cited: 21
A guide through conventional and modern cancer treatment modalities: A specific focus on glioblastoma cancer therapy (Review)
Rayan Naser, Hrag Dilabazian, Hadi Bahr, et al.
Oncology Reports (2022) Vol. 48, Iss. 5
Open Access | Times Cited: 20
Radioprotectors, Radiomitigators, and Radiosensitizers
Alegría Montoro, Elena Obrador, Dhruti Mistry, et al.
Springer eBooks (2023), pp. 571-628
Closed Access | Times Cited: 12
Preclinical characterization of the absorption and disposition of the brain penetrant PI3K/mTOR inhibitor paxalisib and prediction of its pharmacokinetics and efficacy in human
Laurent Salphati, Jodie Pang, Bruno Alicke, et al.
Xenobiotica (2024) Vol. 54, Iss. 2, pp. 64-74
Closed Access | Times Cited: 4
Microbubble-Enhanced Focused Ultrasound for Infiltrating Gliomas
Alexandra A. Seas, Adarsha P. Malla, Nima Sharifai, et al.
Biomedicines (2024) Vol. 12, Iss. 6, pp. 1230-1230
Open Access | Times Cited: 4
Variability in radiotherapy outcomes across cancer types: a comparative study of glioblastoma multiforme and low-grade gliomas
Alexander Veviorskiy, Garik V. Mkrtchyan, А. Н. Осипов, et al.
Aging (2025)
Open Access
SAMD9 Is Relating With M2 Macrophage and Remarkable Malignancy Characters in Low-Grade Glioma
Wenping Ma, Kenan Zhang, Zhaoshi Bao, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 26
Therapeutic strategies of recurrent glioblastoma and its molecular pathways ‘Lock up the beast’
Shaimaa M. El-khayat, Waleed Arafat
ecancermedicalscience (2021) Vol. 15
Open Access | Times Cited: 24
Antibody-drug conjugates: beyond current approvals and potential future strategies
Siddharth Menon, Sagun Parakh, Andrew M. Scott, et al.
Exploration of Targeted Anti-tumor Therapy (2022), pp. 252-277
Open Access | Times Cited: 18
Immuno-PET Imaging of CD69 Visualizes T-Cell Activation and Predicts Survival Following Immunotherapy in Murine Glioblastoma
Michal Nisnboym, Sarah R. Vincze, Zujian Xiong, et al.
Cancer Research Communications (2023) Vol. 3, Iss. 7, pp. 1173-1188
Open Access | Times Cited: 10
Targeted therapies for Glioblastoma multiforme (GBM): State‐of‐the‐art and future prospects
S. Satish, Maithili Athavale, Prashant S. Kharkar
Drug Development Research (2024) Vol. 85, Iss. 7
Closed Access | Times Cited: 3
Implications of Oxidative Stress in Glioblastoma Multiforme Following Treatment with Purine Derivatives
Marta Orlicka-Płocka, Agnieszka Fedoruk‐Wyszomirska, Dorota Gurda, et al.
Antioxidants (2021) Vol. 10, Iss. 6, pp. 950-950
Open Access | Times Cited: 21
Novel Concepts of Glioblastoma Therapy Concerning Its Heterogeneity
Gábor Hutóczki, József Virga, Zsuzsanna Birkó, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 18, pp. 10005-10005
Open Access | Times Cited: 19
Physiological Imaging Methods for Evaluating Response to Immunotherapies in Glioblastomas
Sanjeev Chawla, Vanessa Shehu, Pradeep Kumar Gupta, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 8, pp. 3867-3867
Open Access | Times Cited: 18
Page 1 - Next Page

Scroll to top